title: Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Alvarez
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Musteanu
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Garcia-Garcia
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: P P
authors.initials: PP
authors.lastname: Lopez-Casas
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Megias
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Guerra
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Muñoz
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: Y
authors.initials: Y
authors.lastname: Quijano
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Cubillo
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Rodriguez-Pascual
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Plaza
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: de Vicente
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Prados
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Tabernero
authors.affiliation: Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Barbacid
authors.affiliation: Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Lopez-Rios
authors.affiliation: 1] Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050 Madrid, Spain [2] Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Hidalgo
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005347:Fibroblasts / Q000473:pathology*; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy*